Our digital clinic operates under strict Health Canada guidelines, ensuring you receive safe, clinically proven medicationsfrom hormone therapy to medical weight losswith the ongoing support of qualified wellness coaches and clinicians
Semaglutide is a single hormone agonist that targets GLP-1 receptors, while Tirzepatide targets both GLP-1 and GIP receptors
This means it stimulates insulin release mainly when blood sugar is elevated, which lowers the chance of low blood sugar when taken on its own
The FDA does not currently have guidelines on microdosing GLP-1 medications and its clear that more study is needed to understand the risks, benefits, and efficacy of doses that are lower than those recommended by current prescription guidelines
Always consult with a qualified healthcare provider before starting any peptide protocol.] A lot of people using BPC-157 are basing their dosage protocol on bro-science recycled across forums and influencer channels with zero clinical grounding
Nonetheless, the FDA requires that prescribing information include this boxed warning as a precautionary measure